1. Intro slide
2. Neurodegenerative disorders to be discussed
3. Neuropathology of neurodegeneration
4. Neuropathology of ageing
5. Age-associated plaques/tangles accumulation (1)
6. Age-associated plaques/tangles accumulation (2)
7. Neurodegenerative disorders - AD
8. AD: Macroscopic pathology (1)
9. AD: Macroscopic pathology (2)
10. Determination of regional volumes
11. Volume loss correlated to neuron loss
12. Regional atrophy in AD
13. AD: neuropathological diagnosis
14. AD: plaques
15. CERAD criteria
16. AD: neurofibrillary tangles (1)
17. AD: neurofibrillary tangles (2)
18. Braak staging of NFTs
19. NIA-Reagan Institute Criteria
20. Nucleus Basalis of Meynert (NbM)
21. Neuron loss in AD (1)
22. Neuron loss in AD (2)
23. Neurodegenerative disorders - LBD
24. Lewy body diseases
25. LBD: neuropathological diagnosis
26. Spread of Lewy bodies: Braak Staging (1)
27. Spread of Lewy bodies: Braak Staging (2)
28. Regional atrophy in DLB
29. DLB: other pathology
30. Neurodegenerative disorders - FTD
31. FTLD: macroscopic pathology (1)
32. FTLD: macroscopic pathology (2)
33. Regional atropy in FTLD
34. FTLD: disease staging
35. Tauopathy: distribution by stage (1)
36. Tauopathy: distribution by stage (2)
37. FTLD: neuropathological diagnosis
38. FTLD: neuron loss
39. Neurodegenerative disorders - HD
40. Huntington's disease
41. Regional atrophy in HD
42. HD: macroscopic pathology
43. HD: disease staging
44. HD: microscopic pathology (1)
45. HD: microscopic pathology (2)
46. Neurodegenerative disorders - MND
47. Motor Neuron Disease (1)
48. Motor Neuron Disease (2)
49. ALS: microscopic pathology (1)
50. ALS: microscopic pathology (2)
51. Conclusions
52. References
53. Acknowledgements
54. END